✦ LIBER ✦

Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy

✍ Scribed by Graham R. Foster; Robert D. Goldin; Andrew Hay; Michael J. McGarvey; Dr. George R. Stark; Howard C. Thomas

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 670 KB
Volume: 17
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840170502

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Absence of hepatitis B virus precore mut

Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-α

✍ Jianye Xu; David Brown; Tim Harrison; Yue Lin; Geoffrey Dusheiko 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 614 KB

Precore defective HBV mutants may gradually prevail because of immune selection and explain spontaneous seroconversion from HBeAg to anti-HBe in HBV carriers. We have analyzed whether the presence of precore HBV mutants is a determinant of responsiveness to interferon-a therapy. Fifteen carriers (ni

Which patients with chronic hepatitis B

Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors

✍ M. Gary Brook; Peter Karayiannis; Howard C. Thomas 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB 👁 1 views

Twenty-one pretreatment variables were assessed for their significance in response prediction using data from 114 patients given a-interferon for chronic hepatitis B virus infection. In those patients who had received a minimum of 90 million units per m2 total dose over 12 weeks, a negative anti-hum

A mutation in the interferon sensitivity

A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b

✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon

Allogeneic bone marrow transplantation f

Allogeneic bone marrow transplantation for a patient complicated by chronic hepatitis due to precore mutant hepatitis B virus: Failure of management with interferon-α therapy

✍ Miura, Yuji; Takamatsu, Hideyuki; Okumura, Hirokazu; Yoshida, Takashi; Nakao, Sh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 2 views

Selection of genetic variants of the 5?

Selection of genetic variants of the 5? noncoding region of hepatitis C virus occurs only in patients responding to interferon ? therapy

✍ Lu, Mengji; Wiese, Manfred; Roggendorf, Michael 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB 👁 3 views

Interferon ␣ (IFN ␣) can suppress the replication of hepatitis C virus (HCV) in chronically infected patients. However, HCV persists in a significant number of patients despite the normalization of alanine transaminase (ALT) during IFN ␣ therapy. In this study, HCV variants in patients under IFN ␣ t

Efficacy of low-dose intermittent interf

Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy

✍ Norio Akuta; Fumitaka Suzuki; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Yo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

## Abstract The efficacy of interferon (IFN) monotherapy for non‐responders to pegylated interferon (PEG‐IFN) plus ribavirin (RBV) combination therapy is still unclear. To evaluate the impact of IFN monotherapy on biochemical response, 200 consecutive patients infected with HCV genotype 1b, who rec